Details for New Drug Application (NDA): 073403
✉ Email this page to a colleague
NDA 073403 describes QUESTRAN, which is a drug marketed by Bristol Myers and Apothecon and is included in three NDAs. Additional details are available on the QUESTRAN profile page.
The generic ingredient in QUESTRAN is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
The generic ingredient in QUESTRAN is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 073403
| Tradename: | QUESTRAN |
| Applicant: | Apothecon |
| Ingredient: | cholestyramine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1GM RESIN | ||||
| Approval Date: | Apr 28, 1994 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 800MG RESIN | ||||
| Approval Date: | Dec 27, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
